{
    "2018-08-30": [
        [
            {
                "time": "2018-08-30",
                "original_text": "复星医药：重庆食药监局已就信件内容进行飞行检查 结果尚待结论性意见",
                "features": {
                    "keywords": [
                        "复星医药",
                        "飞行检查",
                        "重庆食药监局"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-08-30",
                "original_text": "复星医药遭员工举报：比长生生物更恶劣 多次遭美国FDA警告 诉讼纠纷",
                "features": {
                    "keywords": [
                        "复星医药",
                        "员工举报",
                        "长生生物",
                        "FDA警告",
                        "诉讼纠纷"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-08-30",
                "original_text": "又一个长生生物？复星医药旗下公司遭员工举报",
                "features": {
                    "keywords": [
                        "复星医药",
                        "长生生物",
                        "员工举报"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-08-30",
                "original_text": "复星医药子公司被举报生产和检验记录造假，重庆检查组已入驻 诉讼纠纷",
                "features": {
                    "keywords": [
                        "复星医药",
                        "子公司",
                        "记录造假",
                        "重庆检查组",
                        "诉讼纠纷"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-08-30",
                "original_text": "复星医药回应子公司被举报编造生产记录、骗取GMP证书：不符合事实",
                "features": {
                    "keywords": [
                        "复星医药",
                        "子公司",
                        "生产记录",
                        "GMP证书",
                        "回应"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-30",
                "original_text": "医药行业交9年来最好成绩单 研发投入加码",
                "features": {
                    "keywords": [
                        "医药行业",
                        "研发投入",
                        "成绩单"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-30",
                "original_text": "郭广昌：经济下行有更多投资机会 复星净负债率将控制在60%以下",
                "features": {
                    "keywords": [
                        "郭广昌",
                        "经济下行",
                        "投资机会",
                        "净负债率"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-30",
                "original_text": "复星国际上半年净利同比增长17% 郭广昌：继续推动核心资产对接资本市场",
                "features": {
                    "keywords": [
                        "复星国际",
                        "净利增长",
                        "郭广昌",
                        "核心资产",
                        "资本市场"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-08-30",
                "original_text": "医药行业周报: 国家药监局就药品信息化追溯体系建设征求意见",
                "features": {
                    "keywords": [
                        "医药行业",
                        "国家药监局",
                        "药品追溯体系",
                        "征求意见"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}